Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Tiumbio

    Client Virtual Booth

    TIUMBIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Tiumbio
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    4F, 49, Daewangpangyo-ro 644beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13493
    Telephone
    Telephone
    031-600-1500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.tiumbio.com/en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710
    TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710

    https://www.prnewswire.com/news-releases/tiumbio-submits-cta-for-phase-1b-clinical-trial-of-tu7710-a-long-acting-recombinant-activated-factor-vii-in-hemophilia-a-or-b-patients-302099347.html

    PR NEWSWIRE
    26 Mar 2024
    Share Share
    TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data
    TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data

    https://www.prnewswire.com/news-releases/tiumbio-secures-krw-38-5-billion-in-anticipation-of-upcoming-clinical-data-302023671.html

    PR NEWSWIRE
    29 Dec 2023
    Share Share
    TiumBio and Hansoh Announce Trial Approval of 'HS-10518/TU2670'
    TiumBio and Hansoh Announce Trial Approval of 'HS-10518/TU2670'

    https://www.prnewswire.com/news-releases/tiumbio-and-hansoh-pharma-announce-clinical-trial-approval-of-hs-10518tu2670-from-nmpa-in-china-301869971.html

    PR NEWSWIRE
    05 Jul 2023
    Share Share
    TiumBio inks licensing deal with China's Hansoh for endometriosis drug
    TiumBio inks licensing deal with China's Hansoh for endometriosis drug

    https://www.kedglobal.com/bio-pharma/newsView/ked202208100006

    KEDGLOBAL
    10 Aug 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search